Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 402K | $ -75.97M | $ -75.57M |
3/31/2025 | $ 275K | $ -77.98M | $ -77.7M |
12/31/2024 | $ 12K | $ -82.45M | $ -82.44M |
9/30/2024 | $ 23K | $ -80.13M | $ -80.1M |
6/30/2024 | $ 24K | $ -79.22M | $ -79.19M |
3/31/2024 | $ 152K | $ -85.73M | $ -85.58M |
12/31/2023 | $ 590K | $ -84.71M | $ -84.12M |
9/30/2023 | $ 796K | $ -93.46M | $ -92.66M |
6/30/2023 | $ 1.32M | $ -103.6M | $ -102.28M |
3/31/2023 | $ 1.41M | $ -103M | $ -101.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for ATAI LIFE SCIENCES NV is calculated as follows: CF - Operations [ $ -20.77M ] - CapEx [ $ 59K ]
(=) FCF [ $ -20.82M ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.76M |
median | $ 461K |
std | $ 117.98M |